Campus Science/Technology Officers Gain Stature

Where academic research and commercial enterprise converge, this new breed of college official serves as science's gatekeeper When Katharine Ku took on the directorship of the Office of Technology Licensing at Stanford University earlier this fall, she inherited quite a legacy from her predecessor, Neils Rimers. Her professional endowment included royalties totaling $25.6 million last year; a portfolio of patents and licenses that includes one of the most lucrative and commercially successful

| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

Her professional endowment included royalties totaling $25.6 million last year; a portfolio of patents and licenses that includes one of the most lucrative and commercially successful university patents to date; a faculty that is, as she puts it, "in the middle of Silicon Valley and immersed in the whole entrepreneurial culture"; and a staff of 20 to handle their inventions.

There are as many different paths to a position in technology transfer as there are facets to the job. A chemical engineer by training, Katharine Ku started her career as a patent engineer at Stanford University, helping investigators write descriptions of their inventions. After six years as associate director of technology licensing there, she left Stanford to become vice president of business development at Protein Design Labs Inc. in Palo Alto, Calif. It was from this biotech company that she was recruited back to Stanford this fall. Francis J. Meyer, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Susan L-J Dickinson

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio